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Abstract
External Quality Assessment (EQA) is the verification, on a recurring basis, that laboratory results conform to expectations for the quality required 
for patient care. It is now widely recognised that both the pre- and post-laboratory phase of testing, termed the diagnostic phases, are a significant 
source of laboratory errors. These errors have a direct impact on both the effectiveness of the laboratory and patient safety. Despite this, Australian 
laboratories tend to be focussed on very narrow concepts of EQA, primarily surrounding test accuracy, with little in the way of EQA programs for the 
diagnostic phases. There is a wide range of possibilities for the development of EQA for the diagnostic phases in Australia, such as the utilisation of 
scenarios and health informatics. Such programs can also be supported through advances in health information and communications technology, 
including electronic test ordering and clinical decision support systems. While the development of such programs will require consultation and 
support from the referring doctors, and their format will need careful construction to ensure that the data collected is de-identified and provides 
education as well as useful and informative data, we believe that there is high value in the development of such programs. Therefore, it is our opini-
on that all pathology laboratories should strive to be involved in an EQA program in the diagnostic phases to both monitor the diagnostic process and 
to identify, learn from and reduce errors and near misses in these phases in a timely fashion.
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Introduction
Pathology is a crucial clinical tool, estimated to 
contribute to 60-70% of all critical decisions involv-
ing patient treatment (1). Despite this potential 
value, the Carter review estimated that 25% of pa-
thology requests are unnecessary or inappropriate 
(2). Furthermore, CareTrack Australia examined the 
appropriateness of care provided in Australia for 
22 common conditions and demonstrated that 
only 57% of patients received what was regarded 
as appropriate care (3). The cost of diagnostic test 
services in Australia rose to $5.25 billion in 2013. 
For pathology services, this represented an in-
crease of 81% in the decade to 2013 (4). This rise 
has led to major concerns about the substantial 
costs and risks associated with unnecessary tests 
and incorrect result interpretation. For pathology 
services to be of value, the correct ordering of 
tests and interpretation of results is crucial. This is 
the responsibility of the treating clinician, and as 
such, can be considered as the pre- and post-labo-
ratory or diagnostics phase (5).
External Quality Assessment (EQA) is the verifica-
tion, on a recurring basis, that laboratory results 
conform to expectations for the quality required 
for patient care (6). However, Australian laborato-
ries tend to be focussed on very narrow concepts 
of EQA, even though the significance of pre and 
post laboratory errors is now widely recognized. 
This can be partly attributed to the fact that labo-
ratories are largely sample, as opposed to patient, 
oriented. 
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If the broader concept of Quality Management 
Systems (QMS) is primarily aimed at meeting cus-
tomer requirements and enhancing customer sat-
isfaction, then it is clear that the quality of the 
product of a laboratory is taken as a given by refer-
rers, and enhancing clinician, patient and payer 
satisfaction extends far beyond the traditional 
boundaries of the laboratory. One way to improve 
the quality of service laboratories provide is to ex-
tend laboratory based EQA programs to the re-
questing and reporting phases, which are outside 
the current scope of pre-analytical, analytical and 
post-analytical EQA programs (7). Whilst it is rec-
ognised that some countries have made steps in 
this direction, this is far from widespread, and cur-
rently lacking in Australia. The pre-pre-analytical 
phase, which is primarily composed of test order-
ing, and the post-post-analytical phase, which is 
primarily composed of test result interpretation, 
can be regarded as the diagnostic phases (as op-
posed to the analytical phases) and sub-divide it 
into a pre-laboratory and post-laboratory phase 
(Figure 1). This terminology has been chosen to re-
move the laboratory as the focus of the process 
and shift it back to the referring clinician.
In addition to introducing the diagnostic phase 
terminology, this opinion paper aims to set out the 
reasons why pathology laboratories and diagnos-
tic medicine needs a way of monitoring these 
phases more effectively, with particular reference 
to the Australian situation. It is the belief of the au-
thors that an EQA program could be developed to 
identify, learn from and reduce these errors and 
near misses in a timely fashion, and this will be ex-
plored in this article.
Pre and post-laboratory errors
A study conducted by the American Academy of 
Family Physicians reported that participants sub-
mitted 590 event reports with 966 pre- and post-
laboratory errors. Pre-laboratory errors occurred in 
ordering tests (12.9%) and implementing tests 
(17.9%), while post-laboratory errors occurred in 
reporting results to clinicians (24.6%), clinicians re-
sponding to results (6.6%), notifying patient of re-
sults (6.8%), general administration (17.6%), com-
munication (5.7%) and other categories (7.8%). 
Charting or filing errors alone accounted for 14.5% 
of errors. While patients were unharmed in 54% of 
events, 18% resulted in some harm, and harm sta-
tus was unknown for 28%. Furthermore, these er-
rors led to a range of other adverse consequences 
including time and financial consequences (22%), 
delays in care (24%), pain/suffering (11%) and ad-
verse clinical consequence (2%) (8). Therefore, the 
impact of these pre- and post-laboratory errors 
demonstrates a pressing need to identify the 
sources of these errors to facilitate the develop-
ment of interventions that can reduce the error 
rate. 
While there has been a vast amount of research to 
identify pre-laboratory error quality indicators (9), 
there are also significant pre-laboratory errors that 
we believe have not been included in these indica-
tors. One of these areas of omission is the propor-
tion of patients who are not adherent to a pathol-
ogy request. It has been estimated that in Austral-
ia, approximately 20-30% of patients who are giv-
en a pathology request form in the community do 
not have this request completed (10). There are 
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ing language barriers in communication, low soci-
oeconomic status and poor health literacy such as 
forgetting important appointments, losing pathol-
ogy forms and not showing up to or attempting to 
reschedule the appointment. This has potentially 
far greater impact on patient treatment than the 
analytical phase. 
Primary care in Australia is the responsibility of 
General Practitioners (GPs). The impact of the 
aforementioned non-compliance to test requests 
has required GPs to adopt complex workflows to 
remind patients of the need to have an appropri-
ate test before the next appointment. Anecdotally, 
the non-adherence rates are of a similar range in 
hospital outpatient clinics. The cost to the commu-
nity of these wasted appointments is significant. 
This is one reason why point of care testing, which 
enables laboratory tests to be performed at the 
patient location as opposed to a laboratory, may 
have significant benefits for both patients and 
health professionals.
Hickner et al. reported that GPs described uncer-
tainty in ordering laboratory tests in approximate-
ly 15% of diagnostic encounters (11). The task of se-
lecting appropriate diagnostic testing is challeng-
ing for clinicians, in part because of the sheer vol-
ume of choices. For example, there are currently 
over 850 different pathology tests for which the 
government will reimburse patients in Australia. 
Therefore, methods to improve this workflow 
could lead to a significant improvement in the 
quality of pathology services.
Sikaris has identified the importance of the post-
laboratory phase and how it is subject to error, 
such as the misapplication of appropriate and ac-
curate test results through cognitive failure (12). 
Laboratory tests and their misinterpretation are 
still an important contributor to misdiagnosis be-
cause of the emphasis put on laboratory testing 
for diagnosis and monitoring decisions. In the 
post-laboratory phase the quality of the final re-
port, including its reference intervals, clinical inter-
pretations and notifications based on knowledge 
from laboratory specialists, should support clinical 
decision-making. It has been reported that incor-
rect interpretation of diagnostic tests accounts for 
up to 37% of malpractice claims in primary care 
and emergency departments (13). 
Audit and dissemination of best practice plays an 
important role in managing the quality of results 
interpretation. While audits are not the preferred 
option for the Australian situation, primarily due to 
the great distances required to make on-site visits, 
a number of international studies have examined 
the quality of results interpretation in general 
practice. Skeie et al. found that 22% of Norwegian 
GPs misclassified changes in haemoglobin A1c 
(HbA1c) for patients with diabetes mellitus (DM) 
and that the vast majority of GPs assumed that an-
alytical quality was better than it really was (14). 
The finding of this study are supported by that of 
Thue and Sandberg (15), who analysed clinician 
expectation of analytical performance in relation 
to current analytical performance specifications, 
finding that clinicians are generally uninformed of 
the capability of analytical performance. Three 
subsequent Norwegian studies performed EQA of 
GP’s interpretation of pathology results and 
showed general agreement in critical differences 
(CDs) for blood glucose and HbA1c, with variation 
in the perceived risk to patients of a severe bleed 
(16,17). There was also a large variation in CDs for 
uric acid and in International Normalized Ratio 
(INR) interpretation for warfarin monitoring (17,18). 
Kristoffersen et al. found that GPs across 13 coun-
tries overestimated the risk of ischemic stroke and 
bleeding in people treated with vitamin K antago-
nists (VKA) by 2-3 times (19). The results of these 
studies suggest that guidelines for these condi-
tions may be either unknown or impractical. Hel-
lemons et al., who found that guidelines around 
the use and interpretation of albuminuria in pa-
tients with DM were poorly followed in general 
practice further support this (20). 
EQA programs for the pre- and 
post-laboratory phases
The Institute of Medicine (IOM) report entitled “To 
Err is human” identified the types of error that 
arise in the diagnostic process, namely: failure to 
employ indicated tests; use of outmoded tests or 
therapy; failure to act on results of monitoring or 
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testing; treatment error in the performance of an 
operation, procedure, or test; error in administer-
ing the treatment; error in the dose or method of 
using a drug; avoidable delay in treatment or in re-
sponding to an abnormal test; inappropriate (not 
indicated) care; preventive failure to provide pro-
phylactic treatment; inadequate monitoring or fol-
low-up of treatment; other failures of communica-
tion; equipment failure; other system failure (21). 
Many of these errors, such as failure to order a test, 
wrong test ordered and failure to recognise urgen-
cy, are amenable to the type of EQA programs that 
are used in laboratory medicine. However, devel-
oping EQA programs for the pre- and post-labora-
tory phases will require consultation and support 
from the referring doctors. The format of the pro-
grams will also need careful construction to en-
sure that the data collected is de-identified and 
provides education as well as useful and meaning-
ful data. 
The EQA program we propose could take the form 
of a series of patient scenarios where a response 
would be required. The Interpretative Comment 
programs of The United Kingdom National Exter-
nal Quality Assessment Service (UKNEQAS) or Roy-
al College of Pathologists of Australasia Quality As-
surance Programs (RCPAQAP) are two such exam-
ples; however, the referring doctor would be the 
participant. The results would be analysed and re-
ported back with a guideline-based response, 
concordance, and group performance (see Appen-
dix 1 for an example of such a report). Sikaris has 
described these concepts in terms of a medical 
laboratory, but they are translatable to a referring 
doctor model (12). The cases will need to be care-
fully chosen, however, so that the suggested inter-
pretations in terms of what tests to order based on 
a given clinical scenario or what treatment to sug-
gest has a strong evidence base in both current lit-
erature and current clinical guidelines.
EQA programs for information 
technology 
The purpose of a pathology report is to communi-
cate the results of the test in a clear and unambig-
uous manner. It is clearly a patient safety issue if a 
report is misread in a way that may lead to an in-
correct understanding of the results. Hickner et al. 
found that 8.3% of GPs had uncertainty towards 
interpreting results (11). Challenges included dif-
ferent names for the same test, tests not available 
except as part of a test panel and different tests in-
cluded in panels with the same names. While this 
has been addressed in some countries, it remains 
a prominent issue in the Australian setting. Addi-
tionally if a report is difficult to read, there can be 
valuable time lost in trying to correctly identify the 
key elements of the results. 
In the modern era, doctors commonly receive pa-
thology reports from a range of different laborato-
ries. Examples include tests requested by a spe-
cialist, results from a hospital, results obtained 
while travelling interstate or overseas or results 
from a different laboratory attended by the pa-
tient for convenience or other reasons. Clearly, uni-
formity of reporting formats amongst laboratories 
can be beneficial in making the review of patholo-
gy reports easier and safer, irrespective of the test-
ing laboratory (22). Clear and consistent reporting 
is vital to support safe pathology interpretation. 
Guidelines aimed at improving the effectiveness 
of testing have been the subject of standardisa-
tion between medical groups for a significant pe-
riod of time (23). While there has been focus on 
communication using electronic systems (24,25), 
paper reports remain in common use and ren-
dered reports (e.g. portable document formats 
(PDF) or Pathology Information Transfer protocol 
(PIT) formats) are still widely used in practice. In 
2013, the Royal College of Pathologists Australasia 
(RCPA) published an initial Standard. A group 
known as the Australian Pathology Units and Ter-
minology Standardisation Project (APUTS) wrote 
the draft, and after public feedback, edited and fi-
nalised comments. The Standards and Guidelines 
were released in 2014 to assist in the requesting 
and reporting of pathology (26).
It is now important that conformity to the afore-
mentioned guidelines and standards be moni-
tored. This can be done through a form of EQA for 
reports. An EQA organisation is part of the re-
quest-result cycle and hence is in a position to per-
form quality assurance on the laboratory result 
when the laboratory sends a result back to the EQA. 
The units, format, reference interval and comment 
http://doi.org/10.11613/BM.2017.009 Biochemia Medica 2017;27(1):73–80 
  77
Badrick T. et al. EQA beyond the analytical phase
are all a part of the EQA result and hence can be 
treated as part of the EQA program (Figure 2). 
The Pathology Information, Terminology and Units 
Standardisation (PITUS) Informatics EQA Project 
aims to build a system to enable electronic re-
questing and reporting for an existing RCPAQAP 
EQA program. The electronic messages involved 
in the process will be assessed for compliance and 
conformance to relevant Standards from National 
Pathology Accreditation Advisory Council 
(NPAAC), Australian Standards and the RCPA. A 
rendered PDF version of the report will also be 
generated and assessed against the format, rules 
and rendering conformance requirements of the 
APUTS Standard.
Use of ICT to support EQA in diagnostic 
phase
Advances in Health Information and Communica-
tions Technology (ICT) means that ICT can be used 
to support EQA and assist clinicians when both or-
dering and interpreting pathology test results. 
This combination has the potential to significantly 
reduce errors in the diagnostic phase of pathology 
testing. In the pre-laboratory phase, Computer-
appendix 1. Example report to evaluate pre- and post-diagnostic phases
The clinician would be given a scenario and asked questions, regarding either what tests they would order or what treatment they 
would institute. The scenario could include photos, reports, specialist comments etc. Results would be analysed against an “expert” 
response. The report includes the individual’s response and a summary of all responses, along with the expert’s response with the 
rationale and references. Participants are not “marked” as such, but responses graded according to a system along the lines of pre-
ferred, relevant, less relevant and misleading. 
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ised Physician Order Entry (CPOE) systems allow 
clinicians to enter laboratory orders directly into a 
computer system. This can support EQA systems 
that aim to reduce the chance of errors associated 
with illegible handwriting, patient identification 
and specimen collection and labelling, key sources 
of error in the pre-analytical phase. CPOE systems 
can also be coupled with clinical decision support, 
assisting the clinician to choose the most appro-
priate tests for their patient. However, there is still 
scant evidence around the impact of such systems 
on patient outcomes (27). In one of the few studies 
to date, Georgiou et al. demonstrated that the im-
plementation of a CPOE system led to a reduction 
in errors associated with mislabelled, mismatched 
and unlabelled specimens (28). CPOE also led to a 
reduction in both the number of tests being or-
dered per episode of patient care and laboratory 
turnaround time. These findings have a direct im-
pact on patient safety and quality of care as a sub-
sequent study showed that for every five addition-
al tests, emergency department length of stay in-
creased by 10 minutes and that each 30-minute 
increase in turnaround time was associated with a 
17 minute increase in emergency department 
length of stay (29).
In the post-laboratory phase, ICT can be used to 
support EQA systems that aim to standardise re-
sult reporting, reduce the number of missed test 
results and improve the quality of pathology result 
interpretation. The use of ICT to generate stand-
ardised pathology result reports, such as through 
mobile applications, may decrease the risk of in-
correct result interpretation due to the clinician 
being unfamiliar with the report layout. However, 
the impact of such systems remains to be fully ex-
plored. Electronic test acknowledgement systems, 
which require the clinician to acknowledge that 
they have viewed a pathology result, can also be 
used to reduce the number of missed test results 
(30). Finally, electronic decision support systems 
can also be used in the post-laboratory phase to 
assist clinicians with adhering to guideline or pro-
tocol based care. However, in Australia, evidence 
surrounding the impact of such systems on pa-
tient outcomes remains weak (31). Therefore, while 
further patient centric studies are required to fully 
assess the impact of Health ICT on patient safety, 
ICT combined with EQA has the potential to re-
duce errors in the diagnostic phase of the pathol-
ogy process.
Conclusions
For pathology services to be of value, the correct 
ordering and interpretation of results is crucial. 
Figure 2. Laboratory messaging in context 
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Both of these factors are the responsibility of the 
treating clinician, and as such, can be considered 
as the pre- and post-laboratory phase (5).  Errors 
occur throughout the testing process, most com-
monly involving test implementation and report-
ing results to clinicians. While significant physical 
harm caused by these errors is rare, adverse conse-
quences for patients are common. 
It is a recommendation of the IOM that accredita-
tion organizations have programs in place to en-
sure competencies in the diagnostic phase, and to 
identify and learn from diagnostic errors and near 
misses with an aim to reduce these errors in a 
timely fashion (32). EQA programs are proven ways 
of achieving these goals and have the experience 
and processes in place to provide the required 
platforms. To this end, we believe that widespread 
implementation of such programs, supported by 
ICT, is the next stage of identifying and reducing 
error in the diagnostic phase of the request-result 
cycle.
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